Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension

Agriculture & Biology

• renoprotective effect 100%
• diabetic nephropathy 97%
• hypertension 60%
• kidneys 40%
• sodium glucose cotransporter-2 inhibitors 30%
• rats 29%
• blood glucose 21%
• proteinuria 20%
• glomerular filtration rate 18%
• fibrosis 17%
• blood pressure 13%
• blood flow 13%
• salts 9%
• desoxycorticosterone 9%
• streptozotocin 9%
• kidney diseases 8%
• hypotension 8%
• hyperglycemia 8%
• diabetes 7%
• hypertrophy 7%
• protective effect 6%
• animal models 6%

Medicine & Life Sciences

• empagliflozin 87%
• Diabetic Nephropathies 59%
• Lisinopril 49%
• Hypertension 36%
• Kidney 22%
• Sodium-Glucose Transport Proteins 20%
• Blood Glucose 17%
• Renal Circulation 16%
• Proteinuria 13%
• Blood Pressure 13%
• Glomerular Filtration Rate 13%
• Salts 12%
• Fibrosis 10%
• Wounds and Injuries 10%
• Desoxycorticosterone 9%
• Streptozocin 7%
• Chronic Renal Insufficiency 6%
• Hyperglycemia 6%
• Hypertrophy 6%
• Animal Models 5%
• Elderly 4%
• Weights and Measures 4%
• Therapeutics 2%